Clinical Research News Online
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • Press Releases
    • Post Press Releases
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Recorded Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • Clinical Trainings
    • Clinical Conferences
    • Clinical Trial Innovation Summit
    • Barnett International
  • About
    • Editorial Calendar
    • Editorial Profile
    • Contact Us
    • Submit a Story
  • SCOPE Summit
    • SCOPE Summit – US
    • SCOPE Summit – Europe
    • European Innovations Awards
 
 
 
 
  • GRAIL Initiates The STRIVE Study To Advance Development Of Blood Tests To Detect Cancer Early

    Clinical Informatics News Brief | GRAIL today announced that it has commenced its second multi-center clinical study, the STRIVE Study, to facilitate the development of GRAIL’s blood tests for early-stage cancer detection.

    Apr 20, 2017
  • Google Offshoot Starts A 10000-Person Study To Plumb Human Biology

    Forbes |  Verily, formerly known as Google Life Sciences, is launching a long-awaited study whose methods may offer a realistic blueprint for how tech could change medicine. But it's also an emblem of how long that transformation will take.

    Apr 20, 2017
  • Cures Act: An Important Mile Marker In The Journey To Treat Disease

    Deloitte |  The recently passed 21st Century Cures Act has the potential to be game changing for the drug and device development and approval process.

    Apr 18, 2017
  • China To Tighten Rules Against Faking Clinical Trial Data, Criminal Charges Possible

    FierceBiotech |  China's FDA and Supreme Court, in a seemingly synchronized move, are proposing new actions against forging clinical trial data, and criminal charges are on the table.

    Apr 13, 2017
  • New Report Charts Ways To Expedite Critical Research During Epidemics

    STAT |  The report recommends ways to accelerate clinical trials for future epidemics, hoping to ensure that the lessons from the Ebola outbreak are not forgotten.

    Apr 12, 2017
  • PhRMA Seeks More Transparency on FDA Inspections to Speed First-Cycle Approvals

    RAPS |  The Pharmaceutical Research and Manufacturers of America (PhRMA) last week said it supports the US Food and Drug Administration's (FDA) review of its inspection information flow, particularly as applications that receive on-time inspections typically receive first cycle approvals earlier.

    Apr 11, 2017
  • Navigating A Connected World: Sensors In Clinical Trials And Care

    Clinical Informatics News | Novartis is hoping to answer the vast questions that surround connected sensor data, and how it might be used to improve drug development, clinical trials, and patient care.

    Apr 10, 2017
  • FDA Delays eCTD Requirements for Master Files

    RAPS | The US Food and Drug Administration (FDA) is giving drugmakers an additional year before requiring master files to be submitted in electronic common technical document (eCTD) format.

    Apr 7, 2017
  • It’s About Time: Clinical Trial Visit Simulations

    Clinical Informatics News | It's About Time | Highlighting new ideas for advancing clinical research, Norman Goldfarb speaks with Faye O’Brien from the Global Medicines Development at AstraZeneca about the need to start simulating clinical trial visits.

    Apr 5, 2017
  • Journal Editor Calls For Culture Change Around Clinical Trial Data

    STAT |  A summit convened by NEJM sought to determine the right balance between sharing data from clinical trials and keeping them private.

    Apr 4, 2017
  • Shortcuts In Drug Testing Can Increase Risk To Patients

    NPR.org |  Researchers use intermediate endpoints, like how a drug lowers cholesterol, to get a quick sense of whether the drug might improve health. But those shortcuts often don't show true benefits and harms.

    Apr 4, 2017
  • Move Over Las Vegas: How To Improve The Odds Of Late-Phase Clinical Trial Success

    Clinical Informatics News Contributed Commentary | The transition from phase 2 to phase 3 of a clinical trial has a very low success rate. Modeling and simulation technologies may serve as pivotal tools for reducing late-stage attrition.

    Apr 4, 2017
  • «
  • 201
  • 202
  • 203
  • 204
  • 205
  • 206 (current)
  • 207
  • 208
  • 209
  • 210
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy